Reckitt (GB:RKT)
LSE:RKT
Want to see GB:RKT full AI Analyst Report?
RKT Stock Chart & Stats
5180.00 p
12.00 p(0.24%)
At close: 4:00 PM EST
5180.00 p
12.00 p(0.24%)
Day’s Range― - ―
52-Week Range3,664.00 p - 6,522.92 p
Previous CloseN/A
Volume39.10K
Average Volume (3M)1.55M
Market Cap
£29.11B
Enterprise Value35.74B
Total Cash (Recent Filing)£1.95B
Total Debt (Recent Filing)£8.43B
Price to Earnings (P/E)11.1
Beta0.90
Next Earnings
Jul 29, 2026EPS Estimate
1.5Next Dividend Ex-DateN/A
Dividend Yield3.44%
Share Statistics
EPS (TTM)4.16
Shares Outstanding635,511,400
10 Day Avg. Volume1,239,780
30 Day Avg. Volume1,554,548
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£5,638.60Price Target Upside8.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)3.33
Revenue Forecast (FY)£12.74B
Bulls Say, Bears Say
Bulls Say
Product Innovation & Brand HitsSustained product innovation and successful new launches (including an FDA‑approved Mucinex NDA and multi‑market rollouts) support durable brand relevance, pricing power and shelf presence. This strengthens long‑term organic growth potential and competitive moat in key categories.
Emerging Markets GrowthConsistent, high‑single to double‑digit EM growth (notably China and India) diversifies revenue and drives volume-led expansion. Durable demographic and consumption trends underpin sustained demand, improving resilience versus developed‑market cyclicality and supporting long‑term margin expansion.
Margin Improvement Via Cost ProgramA targeted, material cost‑out program is delivering real fixed‑cost reduction and enabling higher brand investment. Structural lower fixed costs and ongoing BEI support should sustain higher operating margins over the medium term, making profitability improvements more durable.
Bears Say
Weaker Cash Conversion In 2025Despite higher reported earnings, operating cash flow dropped and cash conversion weakened, implying working‑capital or timing issues. Persistent weaker cash conversion would constrain reinvestment, capex flexibility and shareholder returns, reducing financial resilience over the coming quarters.
Stranded Costs & Near‑term Margin RiskA major portfolio divestiture created one‑off stranded costs and a temporary rise in leverage. If cost offsets from restructuring lag or Fuel for Growth underdelivers, margins and free cash flow may be pressured in 2026, slowing deleveraging and increasing execution risk over the medium term.
Regional Performance Pressure (Europe)Persistent weakness and share pressure in Europe, with higher promotional intensity, suggests structural competitive or demand challenges there. Prolonged European underperformance would dampen group growth, constrain margin recovery and require sustained reinvestment to defend brands.
Reckitt News
RKT FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest share price was 3664.00 p and its highest was 6522.92 p in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is £29.11B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Jul 29, 2026 which is in 45 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Mar 05, 2026. The company reported 1.844 p earnings per share for the quarter, missing the consensus estimate of 1.883 p by -0.039 p.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt pays a Quarterly dividend of 127.8 p which represents an annual dividend yield of 3.44%. See more information on Reckitt dividends here
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 1.5.
How many shares outstanding does Reckitt have?
Reckitt has 635,511,400 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of 1.844 p in its last earnings report, missing expectations of 1.883 p. Following the earnings report the stock price went down -5.785%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in GB:RKT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£5,638.60 (8.85% Upside)
£5,638.60 (8.85% Upside)
Blogger Sentiment
Bullish
GB:RKT Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth £2.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.01%
12-Months-Change
Fundamentals
Return on Equity
38.45%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Reckitt
Reckitt Benckiser Group plc is a global enterprise engaged in the production and distribution of consumer goods spanning the health, hygiene, and nutrition sectors. Its commercial reach extends throughout the United Kingdom, the United States, China, India, and numerous other international markets. The company's diverse product portfolio encompasses a wide array of personal health and wellness items. This includes acne treatments (e.g., Clearasil), sexual health products (such as Durex), and digestive aids (like Gaviscon for heartburn and indigestion). It also provides a variety of adult and children's remedies for coughs, colds, and sinus issues (including Mucinex and Delsym), alongside pain relievers (Nurofen, Biofreeze), sore throat medications (Strepsils, Cepacol), and hair removal products (Veet). Reckitt Benckiser also holds a significant presence in specialized nutrition and dietary supplements. Offerings in this segment include adult nutrition products (Mead Johnson), infant and toddler formulas, including iron-fortified hypoallergenic options (Enfamil, Nutramigen), joint health supplements (Move Free), various vitamins, minerals, and general wellness supplements (Airborne), brain health support (Neuriva), Omega fatty acid products (MegaRed), and probiotics (Digestive Advantage, Bodi-Ome). Personal lubricants (K-Y) are also part of this extensive health and wellness range. Within the home care and hygiene segment, the company markets air fresheners (Air Wick), water softening agents (Calgon), and a comprehensive suite of cleaning products for dishes (Finish), toilets (Harpic), and general home surfaces (Cillit Bang, Easy-Off). This is complemented by powerful disinfectants and first aid solutions (Dettol, Lysol), pest control solutions (Mortein), stain removers (Vanish), fabric care items including plant-based options (Woolite, Botanical Origin), and specialized septic tank treatment products (RID-X). Established in 1819, the company maintains its corporate headquarters in Slough, United Kingdom.
RKT Stock 12 Month Forecast
Average Price Target
5,638.60 p
▲(8.85% Upside)
Technical Analysis
Associated British Foods
―
British American Tobacco
―
Coca Cola HBC
―
Imperial Brands
―
Unilever
―
Options Prices
Currently, No data available
---